{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Molecular docking", "Molecular dynamics", "SARS-CoV-2 main protease", "Secondary metabolites", "Spices"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33065388", "DateCompleted": {"Year": "2020", "Month": "11", "Day": "16"}, "DateRevised": {"Year": "2021", "Month": "01", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1016/j.compbiomed.2020.104046", "S0010-4825(20)30377-2"], "Journal": {"ISSN": "1879-0534", "JournalIssue": {"Volume": "126", "PubDate": {"Year": "2020", "Month": "Nov"}}, "Title": "Computers in biology and medicine", "ISOAbbreviation": "Comput Biol Med"}, "ArticleTitle": "In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.", "Pagination": {"StartPage": "104046", "MedlinePgn": "104046"}, "Abstract": {"AbstractText": ["Coronavirus Disease 2019 (COVID-19) is an infectious illness caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), originally identified in Wuhan, China (December 2019) and has since expanded into a pandemic. Here, we investigate metabolites present in several common spices as possible inhibitors of COVID-19. Specifically, 32 compounds isolated from 14 cooking seasonings were examined as inhibitors for SARS-CoV-2 main protease (M<sup>pro</sup>), which is required for viral multiplication. Using a drug discovery approach to identify possible antiviral leads, in silico molecular docking studies were performed. Docking calculations revealed a high potency of salvianolic acid A and curcumin as M<sup>pro</sup> inhibitors with binding energies of -9.7 and -9.2\u00a0kcal/mol, respectively. Binding mode analysis demonstrated the ability of salvianolic acid A and curcumin to form nine and six hydrogen bonds, respectively with amino acids proximal to M<sup>pro</sup>'s active site. Stabilities and binding affinities of the two identified natural spices were calculated over 40 ns molecular dynamics simulations and compared to an antiviral protease inhibitor (lopinavir). Molecular mechanics-generalized Born surface area energy calculations revealed greater salvianolic acid A affinity for the enzyme over curcumin and lopinavir with energies of -44.8, -34.2 and -34.8\u00a0kcal/mol, respectively. Using a STRING database, protein-protein interactions were identified for salvianolic acid A included the biochemical signaling genes ACE, MAPK14 and ESR1; and for curcumin, EGFR and TNF. This study establishes salvianolic acid A as an in silico natural product inhibitor against the SARS-CoV-2 main protease and provides a promising inhibitor lead for in vitro enzyme testing."], "CopyrightInformation": "Copyright \u00a9 2020. Published by Elsevier Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, 61519, Egypt. Electronic address: m.ibrahim@compchem.net."}], "LastName": "Ibrahim", "ForeName": "Mahmoud A A", "Initials": "MAA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, 61519, Egypt."}], "LastName": "Abdelrahman", "ForeName": "Alaa H M", "Initials": "AHM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Department, Faculty of Pharmacy, Deraya University, Minia, Egypt."}], "LastName": "Hussien", "ForeName": "Taha A", "Initials": "TA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, 61519, Egypt."}], "LastName": "Badr", "ForeName": "Esraa A A", "Initials": "EAA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza, 12622, Egypt."}], "LastName": "Mohamed", "ForeName": "Tarik A", "Initials": "TA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, S-106 91, Stockholm, Sweden; International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang, 212013, China."}], "LastName": "El-Seedi", "ForeName": "Hesham R", "Initials": "HR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry & Biochemistry Texas Tech University, Lubbock, TX, 79409 USA."}], "LastName": "Pare", "ForeName": "Paul W", "Initials": "PW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128, Mainz, Germany."}], "LastName": "Efferth", "ForeName": "Thomas", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza, 12622, Egypt; Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128, Mainz, Germany. Electronic address: me.fathy@nrc.sci.eg."}], "LastName": "Hegazy", "ForeName": "Mohamed-Elamir F", "Initials": "MF"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Comput Biol Med", "NlmUniqueID": "1250250", "ISSNLinking": "0010-4825"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Caffeic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Lactates"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Nonstructural Proteins"}, {"RegistryNumber": "51622542XO", "NameOfSubstance": "salvianolic acid A"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Cysteine Endopeptidases"}, {"RegistryNumber": "EC 3.4.22.28", "NameOfSubstance": "Coronavirus 3C Proteases"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": ["enzymology"], "DescriptorName": "Betacoronavirus"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Caffeic Acids"}, {"QualifierName": [], "DescriptorName": "Coronavirus 3C Proteases"}, {"QualifierName": ["drug therapy", "enzymology"], "DescriptorName": "Coronavirus Infections"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Curcumin"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cysteine Endopeptidases"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Lactates"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": ["drug therapy", "enzymology"], "DescriptorName": "Pneumonia, Viral"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Thermodynamics"}, {"QualifierName": ["antagonists & inhibitors", "chemistry"], "DescriptorName": "Viral Nonstructural Proteins"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Woo P.C., Huang Y., Lau S.K., Yuen K.Y. Coronavirus genomics and bioinformatics analysis. Viruses. 2010;2:1804\u20131820.", "ArticleIdList": ["PMC3185738", "21994708"]}, {"Citation": "Yin Y., Wunderink R.G. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23:130\u2013137.", "ArticleIdList": ["PMC7169239", "29052924"]}, {"Citation": "Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G.F., Tan W., China novel coronavirus, T. Research A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727\u2013733.", "ArticleIdList": ["PMC7092803", "31978945"]}, {"Citation": "World Health Organization WHO director-general\u2019s remarks at the media briefing on 2019-nCoV on 11 February. 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 2020 [cited 2020 Apr 2], Available from:"}, {"Citation": "Liu Z., Xiao X., Wei X., Li J., Yang J., Tan H., Zhu J., Zhang Q., Wu J., Liu L. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J. Med. Virol. 2020;92:595\u2013601.", "ArticleIdList": ["PMC7228221", "32100877"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science. 2020;368:409\u2013412.", "ArticleIdList": ["PMC7164518", "32198291"]}, {"Citation": "Coronavirus Update (Live) 2,418,429 cases and 165,739 deaths from COVID\u221219 virus pandemic\u2014worldometer. 2020. https://www.worldometers.info/coronavirus/ Available online. accessed on 20 April."}, {"Citation": "Gbadamosi I.T. Stay safe: helpful herbal remedies in COVID-19 infection. Afr. J. Biomed. Res. 2020;23:131\u2013133."}, {"Citation": "Gbadamosi I.T. 2019. Hidden Treasures of Ethnobotanical Medicine. A Faculty Lecture Delivered at the Faculty of Science, University of Ibadan on 26th June. 2019."}, {"Citation": "Gbadamosi I. A.J.J.o.A.B. Afolayan, in vitro anti-radical activities of extracts of Solanum nigrum (L.) from South Africa. J. App. Biosci. 2016;98:9240\u20139251."}, {"Citation": "Gbadamosi I., Moody J. A.J.E.J.o.M.P. Yekini, Nutritional composition of ten ethnobotanicals used for the treatment of anaemia in Southwest Nigeria. Eur. J. Med. Plants. 2012;2:140\u2013150."}, {"Citation": "Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X., You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W., Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289\u2013293.", "ArticleIdList": ["32272481"]}, {"Citation": "Gordon J.C., Myers J.B., Folta T., Shoja V., Heath L.S., Onufriev A. H++: a server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Res. 2005;33:W368\u2013W371.", "ArticleIdList": ["PMC1160225", "15980491"]}, {"Citation": "Hawkins P.C.D., Skillman A.G., Warren G.L., Ellingson B.A., Stahl M.T. Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and cambridge structural database. J. Chem. Inf. Model. 2010;50:572\u2013584.", "ArticleIdList": ["PMC2859685", "20235588"]}, {"Citation": "OMEGA OpenEye Scientific Software, Santa Fe, NM, USA, 2013."}, {"Citation": "SZYBKI OpenEye Scientific Software, Santa Fe, 2016."}, {"Citation": "Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools 4: automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785\u20132791.", "ArticleIdList": ["PMC2760638", "19399780"]}, {"Citation": "Forli S., Huey R., Pique M.E., Sanner M.F., Goodsell D.S., Olson A.J. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat. Protoc. 2016;11:905\u2013919.", "ArticleIdList": ["PMC4868550", "27077332"]}, {"Citation": "Gasteiger J., Marsili M. Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron. 1980;36:3219\u20133228."}, {"Citation": "Case D.A., Betz R.M., Cerutti D.S., Cheatham T.E., Darden T.A., Duke R.E., Giese T.J., Gohlke H., Goetz A.W., Homeyer N., Izadi S., Janowski P., Kaus J., Kovalenko A., Lee T.S., LeGrand S., Li P., Lin C., Luchko T., Luo R., Madej B., Mermelstein D., Merz K.M., Monard G., Nguyen H., Nguyen H.T., Omelyan I., Onufriev A., Roe D.R., Roitberg A., Sagui C., Simmerling C.L., Botello-Smith W.M., Swails J., Walker R.C., Wang J., Wolf R.M., Wu X., Xiao L., Kollman P.A., AMBER . University of California; San Francisco: 2016. 2016."}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Hegazy M.F. In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors. J. Biomol. Struct. Dyn. 2020:1\u201312.", "ArticleIdList": ["PMC7441803", "32684114"]}, {"Citation": "Ibrahim M.A.A., Abdeljawaad K.A.A., Abdelrahman A.H.M., Hegazy M.F. Natural-like products as potential SARS-CoV-2 M(pro) inhibitors: in-silico drug discovery. J. Biomol. Struct. Dyn. 2020:1\u201313.", "ArticleIdList": ["PMC7443551", "32643529"]}, {"Citation": "Wang J., Wolf R.M., Caldwell J.W., Kollman P.A., Case D.A. Development and testing of a general amber force field. J. Comput. Chem. 2004;25:1157\u20131174.", "ArticleIdList": ["15116359"]}, {"Citation": "Maier J.A., Martinez C., Kasavajhala K., Wickstrom L., Hauser K.E., Simmerling C. Improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theor. Comput. 2015;11:3696\u20133713. ff14SB.", "ArticleIdList": ["PMC4821407", "26574453"]}, {"Citation": "Bayly C.I., Cieplak P., Cornell W., Kollman P.A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model, J. Phys. Chem. 1993;97:10269\u201310280."}, {"Citation": "Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Scalmani G., Barone V., Mennucci B., Petersson G.A., Nakatsuji H., Caricato M., Li X., Hratchian H.P., Izmaylov A.F., Bloino J., Zheng G., Sonnenberg J.L., Hada M., Ehara M., Toyota K., Fukuda R., Hasegawa J., Ishida M., Nakajima T., Honda Y., Kitao O., Nakai H., Vreven T., Montgomery J.A., Peralta J.E., Ogliaro F., Bearpark M., Heyd J.J., Brothers E., Kudin K.N., Staroverov V.N., Kobayashi R., Normand J., Raghavachari K., Rendell A., Burant J.C., Iyengar S.S., Tomasi J., Cossi M., Rega N., Millam J.M., Klene M., Knox J.E., Cross J.B., Bakken V., Adamo C., Jaramillo J., Gomperts R., Stratmann R.E., Yazyev O., Austin A.J., Cammi R., Pomelli C., Ochterski J.W., Martin R.L., Morokuma K., Zakrzewski V.G., Voth G.A., Salvador P., Dannenberg J.J., Dapprich S., Daniels A.D., Farkas \u00d6., Foresman J.B., Ortiz J.V., Cioslowski J., Fox D.J. 2009. Gaussian 09, Gaussian inc., wallingford CT, USA."}, {"Citation": "Massova I., Kollman P.A. Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspect. Drug Discov. Des. 2000;18:113\u2013135."}, {"Citation": "Zhao Y.H., Abraham M.H., Le J., Hersey A., Luscombe C.N., Beck G., Sherborne B., Cooper I. Rate-limited steps of human oral absorption and QSAR studies. Pharm. Res. (N. Y.) 2002;19:1446\u20131457.", "ArticleIdList": ["12425461"]}, {"Citation": "Heberle H., Meirelles G.V., da Silva F.R., Telles G.P., Minghim R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinf. 2015;16:169\u2013175.", "ArticleIdList": ["PMC4455604", "25994840"]}, {"Citation": "Li R., Ma X., Song Y., Zhang Y., Xiong W., Li L., Zhou L. Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental data. J. Cell. Biochem. 2019;120:11265\u201311273.", "ArticleIdList": ["30719773"]}, {"Citation": "Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u20132504.", "ArticleIdList": ["PMC403769", "14597658"]}, {"Citation": "Lin L.T., Hsu W.C., Lin C.C. Antiviral natural products and herbal medicines. J. Tradit. Complementary Med. 2014;4:24\u201335.", "ArticleIdList": ["PMC4032839", "24872930"]}, {"Citation": "Chandwani A., Shuter J. Lopinavir/ritonavir in the treatment of HIV-1 infection: a review. Therapeut. Clin. Risk Manag. 2008;4:1023\u20131033.", "ArticleIdList": ["PMC2621403", "19209283"]}, {"Citation": "Lee G.A., Seneviratne T., Noor M.A., Lo J.C., Schwarz J.M., Aweeka F.T., Mulligan K., Schambelan M., Grunfeld C. The metabolic effects of lopinavir/ritonavir in HIV-negative men, AIDS. 2004;18:641\u2013649.", "ArticleIdList": ["PMC3166345", "15090769"]}, {"Citation": "Cao B., Wang Y., Wen D., Liu W., Wang J., Fan G., Ruan L., Song B., Cai Y., Wei M., Li X., Xia J., Chen N., Xiang J., Yu T., Bai T., Xie X., Zhang L., Li C., Yuan Y., Chen H., Li H., Huang H., Tu S., Gong F., Liu Y., Wei Y., Dong C., Zhou F., Gu X., Xu J., Liu Z., Zhang Y., Li H., Shang L., Wang K., Li K., Zhou X., Dong X., Qu Z., Lu S., Hu X., Ruan S., Luo S., Wu J., Peng L., Cheng F., Pan L., Zou J., Jia C., Wang J., Liu X., Wang S., Wu X., Ge Q., He J., Zhan H., Qiu F., Guo L., Huang C., Jaki T., Hayden F.G., Horby P.W., Zhang D., Wang C. A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19, new engl. J. Med. 2020;382:1787\u20131799.", "ArticleIdList": ["PMC7121492", "32187464"]}, {"Citation": "Ye X.T., Luo Y.L., Xia S.C., Sun Q.F., Ding J.G., Zhou Y., Chen W., Wang X.F., Zhang W.W., Du W.J., Ruan Z.W., Hong L. Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019. Eur. Rev. Med. Pharmacol. Sci. 2020;24:3390\u20133396.", "ArticleIdList": ["32271456"]}, {"Citation": "Pantsar T., Poso A. Binding affinity via docking: fact and fiction. Molecules. 2018;23:1899\u20131909.", "ArticleIdList": ["PMC6222344", "30061498"]}, {"Citation": "Pagadala N.S., Syed K., Tuszynski J. Software for molecular docking: a review. Biophys. Rev. 2017;9:91\u2013102.", "ArticleIdList": ["PMC5425816", "28510083"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., Muller M.A., Drosten C., Pohlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u2013280. e278.", "ArticleIdList": ["PMC7102627", "32142651"]}, {"Citation": "Palau V., Riera M., Soler M.J. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol. Dial. Transplant. 2020;35:1071\u20131072.", "ArticleIdList": ["PMC7184459", "32291449"]}]}], "History": [{"Year": "2020", "Month": "7", "Day": "31"}, {"Year": "2020", "Month": "10", "Day": "6"}, {"Year": "2020", "Month": "10", "Day": "6"}, {"Year": "2020", "Month": "10", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "16", "Hour": "20", "Minute": "13"}, {"Year": "2020", "Month": "10", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33065388", "PMC7543985", "10.1016/j.compbiomed.2020.104046", "S0010-4825(20)30377-2"]}}]}